Judy Young

2.2k total citations
20 papers, 1.1k citations indexed

About

Judy Young is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Judy Young has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Judy Young's work include Hematopoietic Stem Cell Transplantation (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Judy Young is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Judy Young collaborates with scholars based in United States, Switzerland and Canada. Judy Young's co-authors include Owen N. Witte, Alexander J. Muller, Dan R. Littman, Ann Marie Pendergast, Michael R. Sussman, Frans E. Tax, Patrick J. Krysan, Lesley Murray, Beth L. Hill and Roland Scollay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Judy Young

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy Young United States 13 589 447 275 210 197 20 1.1k
Marie Havlik United States 13 580 1.0× 527 1.2× 354 1.3× 141 0.7× 99 0.5× 15 1.1k
Christopher A. Bristow United States 15 586 1.0× 215 0.5× 150 0.5× 243 1.2× 65 0.3× 30 995
Donatella Venturelli Italy 23 1.1k 1.8× 638 1.4× 418 1.5× 307 1.5× 24 0.1× 58 1.8k
Keisuke Aoyama Japan 16 402 0.7× 248 0.6× 131 0.5× 152 0.7× 66 0.3× 21 855
Richard C. Gregory United States 15 1.1k 1.8× 133 0.3× 71 0.3× 422 2.0× 94 0.5× 34 1.5k
Patricia M. Rosten Canada 14 915 1.6× 310 0.7× 170 0.6× 247 1.2× 16 0.1× 17 1.4k
Jutta Deckert United States 11 666 1.1× 186 0.4× 76 0.3× 295 1.4× 57 0.3× 28 1.0k
Laurent Malivert France 11 915 1.6× 112 0.3× 125 0.5× 333 1.6× 43 0.2× 11 1.1k
Bart Steiner United States 10 518 0.9× 138 0.3× 480 1.7× 203 1.0× 47 0.2× 17 1.0k
Erica N Evans United States 19 487 0.8× 232 0.5× 288 1.0× 187 0.9× 14 0.1× 44 1.2k

Countries citing papers authored by Judy Young

Since Specialization
Citations

This map shows the geographic impact of Judy Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Young more than expected).

Fields of papers citing papers by Judy Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Young. The network helps show where Judy Young may publish in the future.

Co-authorship network of co-authors of Judy Young

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Young. A scholar is included among the top collaborators of Judy Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Young. Judy Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gichane, Margaret W., Ifeyinwa V. Asiodu, Brittany D. Chambers, et al.. (2024). Virtual Research Prioritization: Innovations for Research Agenda Development With Impacted Communities. International Journal of Qualitative Methods. 23.
2.
Liu, Scot D., Cécile Chalouni, Judy Young, et al.. (2014). Afucosylated Antibodies Increase Activation of FcγRIIIa-Dependent Signaling Components to Intensify Processes Promoting ADCC. Cancer Immunology Research. 3(2). 173–183. 51 indexed citations
3.
Mai, Elaine, Zhong Zheng, Youjun Chen, et al.. (2013). Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab. Molecular Cancer Therapeutics. 13(2). 540–552. 10 indexed citations
4.
Xiang, Hong, Brendan C. Bender, Arthur E. Reyes, et al.. (2013). Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development. Clinical Cancer Research. 19(18). 5068–5078. 28 indexed citations
5.
Kauder, Steven E., Lydia Santell, Elaine Mai, et al.. (2013). Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele. PLoS ONE. 8(12). e83958–e83958. 17 indexed citations
6.
Landgraf, Kyle E., Lydia Santell, Karen L. Billeci, et al.. (2010). Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling. Journal of Biological Chemistry. 285(51). 40362–40372. 16 indexed citations
7.
Young, Judy, Chengyou Du, Lidia Sambucetti, et al.. (2004). Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy. 6(4). 328–336. 51 indexed citations
8.
Young, Judy, et al.. (2001). Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines. Cytotherapy. 3(4). 307–320. 13 indexed citations
9.
Murray, Lesley, Judy Young, Linda J. Osborne, et al.. (1999). Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+Thy-1+ cells into rapid division. Experimental Hematology. 27(6). 1019–1028. 108 indexed citations
11.
12.
Young, Judy, et al.. (1996). Hierarchical Structure of Human Megakaryocyte Progenitor Cells. Stem Cells. 14(S1). 75–81. 8 indexed citations
13.
Young, Judy, et al.. (1996). In vitro characterization of fetal hematopoietic stem cells: Range and kinetics of cell production from individual stem cells. Biotechnology and Bioengineering. 50(5). 465–478. 6 indexed citations
14.
Krysan, Patrick J., Judy Young, Frans E. Tax, & Michael R. Sussman. (1996). Identification of transferred DNA insertions within Arabidopsis genes involved in signal transduction and ion transport.. Proceedings of the National Academy of Sciences. 93(15). 8145–8150. 217 indexed citations
15.
Young, Judy, Mikhail L. Gishizky, & Owen N. Witte. (1991). Hyperexpression of Interleukin-7 Is Not Necessary or Sufficient for Transformation of a Pre-B Lymphoid Cell Line. Molecular and Cellular Biology. 11(2). 854–863. 25 indexed citations
16.
Muller, Alexander J., Judy Young, Ann Marie Pendergast, et al.. (1991). BCR First Exon Sequences Specifically Activate the BCR/ABL Tyrosine Kinase Oncogene of Philadelphia ChromosomePositive Human Leukemias. Molecular and Cellular Biology. 11(4). 1785–1792. 97 indexed citations
17.
Muller, Alexander J., et al.. (1991). BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.. Molecular and Cellular Biology. 11(4). 1785–1792. 355 indexed citations
18.
Young, Judy & Owen N. Witte. (1988). Selective Transformation of Primitive Lymphoid Cells by the BCR / ABL Oncogene Expressed in Long-Term Lymphoid or Myeloid Cultures. Molecular and Cellular Biology. 8(10). 4079–4087. 70 indexed citations
19.
Young, Judy, Eric C. Liebl, & Greg S. Martin. (1988). A host-dependent temperature-sensitive mutant of rous sarcoma virus: Evidence for host factors affecting transformation. Virology. 166(2). 561–572. 6 indexed citations
20.
Pfaff, Samuel L., Renping Zhou, Judy Young, Joel S. Hayflick, & Peter Duesberg. (1985). Defining the borders of the chicken proto-fps gene, a precursor of Fujinami sarcoma virus. Virology. 146(2). 307–314. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026